GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Silk Road Medical Inc
Silk Road Medical has developed an innovative, less invasive procedure for treating carotid artery disease. Its stock price reflects the pace of surgeon adoption of this technology. This chart tells the story of a medical breakthrough and its commercialization.
Share prices of companies in the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a minimally invasive TCAR procedure to reduce the risk of stroke in patients with carotid artery disease. We have classified it as a "Therapeutic Medical Device." The chart below shows how investors rate innovations in vascular surgery.
Broad Market Index - GURU.Markets
Silk Road Medical has developed and commercialized a minimally invasive TCAR procedure to reduce the risk of stroke in patients with carotid artery disease. As an innovator, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Silk Road's performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
SILK - Daily change in the company's share price Silk Road Medical Inc
Silk Road Medical, Inc.'s daily price change reflects volatility in the medical device sector. The metric is sensitive to sales of its carotid artery treatment system, serving as an indicator of innovation.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Silk Road Medical has developed an innovative system for treating carotid artery disease, reducing the risk of stroke. The vascular surgery equipment market is highly technological. The chart below shows the volatility in this sector, allowing us to assess how the market is accepting SILK's innovations.
Daily change in the price of a broad market stock, index - GURU.Markets
Silk Road Medical produces devices for treating carotid artery disease, reducing the risk of stroke. The medtech company's stock performance depends on the adoption of its technology in surgical practice. Such unique stories are part of a larger market whose overall volatility you can see.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Silk Road Medical Inc
For Silk Road Medical, Inc., year-over-year performance is a story of its innovative approach to stroke treatment. Its 12-month market cap growth reflects the growing number of hospitals using its TCAR® system, which enables minimal-risk carotid artery stenting, making it the new standard in vascular surgery.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Silk Road, a medical device company, has developed an innovative method for treating carotid artery disease. Its performance relative to the industry will determine how well its technology is accepted in the market and how it is impacted by efforts to obtain insurance coverage, a key driver of its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Silk Road Medical, with its innovative stroke prevention method, is a growth story in medical technology. Its ability to stay ahead of the market depends on how quickly surgeons adopt its less invasive procedure. It's a classic story of how a new technology gains acceptance in medicine.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Silk Road Medical Inc
Silk Road is a manufacturer of medical devices for the treatment of carotid arteries. Its monthly growth reflects growing sales of its TCAR system. Quarterly revenue reports and the implementation of its procedure in new hospitals are the main drivers.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Silk Road Medical has developed and markets an innovative system for carotid artery treatment that reduces the risk of stroke during the procedure. The graph below shows the overall trend in the therapeutic equipment sector, reflecting the demand for less invasive and safer surgical technologies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Silk Road Medical has developed an innovative system for treating carotid artery disease and preventing strokes. As a medical technology company, its growth depends on the speed of adoption of its technology by surgeons. Share price performance is driven by these specific factors, not by general market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Silk Road Medical Inc
Silk Road Medical shares reflect the fight against strokes on a weekly basis. The price movement of this medical company, which has developed a less invasive method for treating carotid artery disease, reflects the pace of surgeon adoption of its procedure.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Silk Road Medical has developed an innovative system for treating carotid artery disease and preventing strokes. This chart compares its weekly performance with the medical equipment sector and helps us understand how its less invasive approach is helping it gain market share from traditional surgery.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Silk Road Medical produces devices for treating carotid artery disease. Demand for its products is driven by urgent medical needs. The chart below will help you determine whether Silk Road shares are truly a "safe haven" asset, demonstrating stability amid market uncertainty.
Market capitalization of the company, segment and market as a whole
SILK - Market capitalization of the company Silk Road Medical Inc
The Silk Road market capitalization chart tells the story of a company that developed a less invasive method for treating carotid artery disease and preventing strokes. Its growth chart reflects the successful implementation of this new technology into clinical practice. Its dynamics reflect the market's assessment of its potential to become a new standard of care.
SILK - Share of the company's market capitalization Silk Road Medical Inc within the market segment - Therapeutic medical equipment
Silk Road Medical develops devices for stroke prevention. Its significant market share in its medical device segment reflects the commercial success of its innovative approach. The chart below shows how the market evaluates its technology compared to traditional treatments.
Market capitalization of the market segment - Therapeutic medical equipment
Silk Road Medical is a medical company that has developed a less invasive method for preventing strokes. The chart below shows the overall market capitalization of this sector. Its dynamics reflect the drive to create safer and more effective surgical procedures, where Silk Road's technology represents a significant advance.
Market capitalization of all companies included in a broad market index - GURU.Markets
Silk Road Medical has developed an innovative procedure for treating the carotid artery to prevent stroke. Its growth reflects how new, less invasive methods are displacing traditional surgery. Its growth on the overall chart is the pulse of progress in vascular surgery.
Book value capitalization of the company, segment and market as a whole
SILK - Book value capitalization of the company Silk Road Medical Inc
Silk Road Medical's book value is its capital and production capacity for producing an innovative system for treating carotid arteries, reducing the risk of stroke. This is real, knowledge-intensive capital for safer vascular surgery. How has this medical technology asset grown? The chart below demonstrates its impressive growth.
SILK - Share of the company's book capitalization Silk Road Medical Inc within the market segment - Therapeutic medical equipment
Silk Road Medical produces devices for the treatment of carotid artery disease (TCAR). The chart shows the proportion of its manufacturing and R&D assets, reflecting the scale of its innovative and less invasive approach to stroke prevention.
Market segment balance sheet capitalization - Therapeutic medical equipment
Silk Road, a medical device manufacturer, is a capital-intensive business. It requires cleanroom facilities to create its carotid artery treatment systems. The BCap_Seg chart for the medical device sector shows that success requires a robust manufacturing base.
Book value of all companies included in the broad market index - GURU.Markets
Silk Road Medical's assets are not its drugs, but its patented TCAR system for transcarotid arterial revascularization, which prevents strokes. Its balance sheet reflects its patents and manufacturing equipment. The chart shows the net worth of this vascular surgery innovator.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Silk Road Medical Inc
Silk Road Medical has developed an innovative system for stroke prevention. Its balance sheet consists of patents and manufacturing capacity. Its market capitalization reflects the medical community's and investors' belief in the superiority of its technology over traditional methods. The chart shows the premium for a medical breakthrough.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a less invasive system for treating carotid artery disease to prevent stroke. Its high market valuation on the chart reflects the value of its unique medical technology and its rapid market growth.
Market to book capitalization ratio for the market as a whole
Silk Road Medical, Inc. develops medical devices to prevent strokes. The company's value is based on its unique technology and patents. This chart shows the premium investors are willing to pay for medical technology innovations aimed at solving critical medical problems.
Debts of the company, segment and market as a whole
SILK - Company debts Silk Road Medical Inc
Silk Road Medical, a company that developed a less invasive procedure for treating carotid artery stenosis, is using capital to expand its commercial team and conduct clinical trials. This chart shows how the MedTech company is funding its efforts to change the standard of care and convince surgeons of the benefits of its approach.
Market segment debts - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a less invasive procedure for treating carotid artery disease. Implementing a new medical technology requires significant investment in physician training and clinical data. This chart shows how the company is funding its aggressive commercial expansion and growth in the vascular surgery market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Silk Road Medical Inc
Silk Road Medical has developed an innovative system for treating the carotid artery to prevent stroke. This chart shows how the fast-growing medical company is using debt capital to finance the commercialization of its product, including expanding its sales team and training physicians. It helps assess its financial risks.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Silk Road Medical has developed a minimally invasive procedure (TCAR) for treating carotid artery disease and preventing stroke. This is a significant innovation in vascular surgery. The chart shows the overall debt burden in the medical device sector, which helps assess how the company is funding the commercialization of its breakthrough technology.
Debt to book value of all companies in the market
Silk Road Medical, Inc. has developed an innovative procedure to prevent strokes, which requires investment in physician training and clinical data. This chart shows the overall debt burden in the market. It helps understand how a medical technology company manages its capital after commercialization to ensure widespread adoption.
P/E of the company, segment and market as a whole
P/E - Silk Road Medical Inc
Silk Road Medical has developed a system for transcarotid arterial revascularization (TCAR), a minimally invasive procedure for preventing stroke. This chart shows how the market is valuing its breakthrough technology. High values reflect the rapid growth of surgeon adoption of this procedure.
P/E of the market segment - Therapeutic medical equipment
Carotid artery treatment, where Silk Road Medical offers its technology, is an innovative sector. This chart shows the average rating for medical device companies. It helps to understand that Silk Road is being evaluated based on its potential to make carotid artery stenting less invasive and safer, potentially setting a new standard.
P/E of the market as a whole
Silk Road Medical is a medical company that has developed a less invasive method for treating carotid artery stenosis to prevent stroke. Its growth depends on surgeons adopting its procedure. Its business is driven by medical needs, not by the general economic cycles reflected in this chart.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Silk Road Medical Inc
This chart from Silk Road Medical, Inc., a company that developed a minimally invasive procedure to prevent strokes, shows market expectations for future sales. It reflects forecasts for the growth in the number of doctors and hospitals implementing its innovative TCAR technology.
%20P%2FE%20Silk%20Road%20Medical%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Silk-Road-Medical-Inc&v=1772513750193 "Chart of the company's future (projected) P/E Silk Road Medical Inc")
Future (projected) P/E of the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized the minimally invasive TCAR procedure for treating carotid artery disease and reducing the risk of stroke. It is a less invasive alternative to traditional surgery. The chart shows forecasts for the medical device sector, helping to assess the market's confidence in TCAR's potential to become a new standard of care in this field.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772513750201 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
Silk Road Medical, Inc. has developed an innovative, less invasive procedure for treating carotid artery disease and preventing stroke. This is a growing market in the MedTech sector. This market sentiment chart influences how investors evaluate companies offering new standards in surgery.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513750203 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Silk Road Medical Inc
Silk Road Medical has developed and markets a transcarotid artery resection (TCAR) system that reduces the risk of stroke. The company's profits depend on the implementation of this procedure in hospitals. This chart illustrates how an innovative medical technology gains recognition and becomes a new standard of care, turning into a profitable business.
Profit of companies in the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a minimally invasive TCAR procedure for treating carotid artery stenosis and preventing stroke. This graph, which reflects sector profitability, demonstrates how innovations are making surgeries safer. Their technology reduces the risk of stroke during the procedure, changing the standard of care for this dangerous condition.
Overall market profit
Silk Road Medical has developed and commercialized a less invasive procedure to prevent stroke in patients with carotid stenosis. The company is a leader in its niche. Growth depends on the adoption of its technology by surgeons. Overall economic stability, reflected in the graph, is essential for the healthcare system to afford such innovative treatments.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Silk Road Medical Inc
Silk Road Medical has developed an innovative system for transcarotid arterial stenting (TCAR), a less invasive method for preventing strokes. This graph reflects analysts' expectations for the rate of adoption of this procedure by vascular surgeons, which is key to capturing market share in the vast medical field.
%20profit%20of%20the%20company%20Silk%20Road%20Medical%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Silk-Road-Medical-Inc&v=1772513750211 "Graph of future (projected) profit of the company Silk Road Medical Inc")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a minimally invasive procedure (TCAR) to treat carotid atherosclerosis and reduce the risk of stroke. The company's growth depends on the acceptance of its technology by surgeons. This chart for the medical device sector illustrates the general expectations for the adoption of innovative and less invasive surgical techniques.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772513750221 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
Silk Road Medical produces devices for stroke prevention. Demand for its products depends on the number of surgeries performed and the acceptance of the technology by the medical community. The overall economic situation, reflected in this graph, impacts hospital budgets, which may affect the speed of implementation of new procedures.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513750225 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Silk Road Medical Inc
Silk Road Medical has developed and commercialized a minimally invasive procedure for treating carotid artery disease and preventing stroke. The chart shows a high valuation for each dollar of its revenue. This reflects investors' belief that its technology is becoming a new standard of care and the significant growth potential in the vascular surgery market.
P/S market segment - Therapeutic medical equipment
Silk Road Medical has developed an innovative transcarotid arterial stenting (TCAR) system, a less invasive stroke prevention method. The company's revenue is growing as this technology is adopted. This chart shows the average valuation in the medical device sector, helping to understand how the market values Silk Road Medical's breakthrough solution.
P/S of the market as a whole
Silk Road Medical has developed and markets an innovative system for treating carotid artery disease that reduces the risk of stroke during the procedure. This chart, showing the average market revenue estimate, serves as a benchmark for Silk Road. It helps understand how highly investors value medical technologies that make dangerous surgeries safer.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Silk Road Medical Inc
Silk Road Medical is a medical technology company that has developed a less invasive procedure (TCAR) for treating the carotid artery to prevent stroke. This chart shows how investors view the future adoption of this innovative procedure as a standard of care, which is the primary driver of sales growth.
%20P%2FS%20Silk%20Road%20Medical%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Silk-Road-Medical-Inc&v=1772513750243 "The graph of the company's future (projected) P/S Silk Road Medical Inc")
Future (projected) P/S of the market segment - Therapeutic medical equipment
Silk Road Medical, Inc. is a medical device company that developed and commercialized TCAR, a minimally invasive procedure to reduce the risk of stroke in patients with carotid artery disease. This chart shows the average future sales estimate for the medical device sector. It helps understand how the market views Silk Road's innovative approach.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772513750254 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
Silk Road Medical has developed and commercialized an innovative, less invasive procedure for treating carotid artery stenosis to prevent stroke. This chart reflects overall investor sentiment. The company's growth depends on surgeons adopting its method, exemplifying how breakthrough technologies are transforming medical practice.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513750255 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Silk Road Medical Inc
This chart shows the revenue of Silk Road Medical, a company that produces a medical device to prevent strokes during carotid artery surgery. Sales are generated from sales of its TCAR system. The trend reflects the adoption of this less invasive procedure by surgeons and hospitals.
Sales of companies in the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a minimally invasive procedure (TCAR) for the treatment of carotid artery stenosis and stroke prevention. This graph illustrates the growth of the therapeutic medical device market. The company's innovative approach has become a new standard of treatment, offering a safer alternative to traditional surgery and expanding the overall market.
Overall market sales
Silk Road Medical develops devices for stroke prevention. Demand for its products depends on the number of surgical procedures performed. The overall economic situation, reflected in this graph, affects hospital budgets and their ability to purchase innovative medical equipment for the treatment of vascular diseases.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Silk Road Medical Inc
Silk Road Medical has developed and markets an innovative system for preventing strokes during carotid artery surgery. The company's future revenue depends on the acceptance of its procedure by surgeons. This chart shows analysts' forecasts for the adoption of this unique medical technology.
%20sales%20of%20the%20company%20Silk%20Road%20Medical%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Silk-Road-Medical-Inc&v=1772513750262 "Schedule of future (projected) sales of the company Silk Road Medical Inc")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a minimally invasive TCAR procedure for treating carotid artery disease and reducing the risk of stroke. This approach is a safer alternative to traditional surgery. This chart shows the forecast for the entire therapeutic medical device market, where Silk Road Medical is changing the standard of care.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772513750265 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
Silk Road Medical has developed and markets a system to reduce the risk of stroke during carotid artery stenting. Demand for their products depends on the number of procedures performed. This demand, reflecting the overall state of the healthcare system, influences hospital budgets and their willingness to implement new, safer medical technologies.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513750266 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Silk Road Medical Inc
Silk Road Medical has developed and markets an innovative system for treating carotid artery disease that reduces the risk of stroke. The company's profitability depends on surgeons adopting its technology. This chart shows how the company, by offering a safer treatment for a serious condition, is turning it into a fast-growing, high-margin business.
Market segment marginality - Therapeutic medical equipment
Silk Road Medical has developed and commercialized a new, less invasive approach to treating the carotid artery to prevent stroke, known as TCAR. Profitability depends on surgeon acceptance of the procedure and increased sales of their disposable devices. This chart shows the commercial success of their innovative medical technology and its impact on treatment standards.
Market marginality as a whole
Silk Road Medical is a medical company that has developed a less invasive procedure (TCAR) for treating carotid artery stenosis to prevent stroke. This overall profitability chart is not directly relevant to them. Their growth depends on surgeons' acceptance of their innovative procedure and demonstrating its advantages over traditional methods.
Employees in the company, segment and market as a whole
Number of employees in the company Silk Road Medical Inc
Silk Road Medical has developed an innovative procedure to prevent strokes. A key factor in its growth is its large direct sales team, which trains surgeons. This graph clearly demonstrates its commercial success and the rapid adoption of its technology in hospitals.
Share of the company's employees Silk Road Medical Inc within the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized an innovative stroke prevention procedure. This chart reflects the scale of its commercial operations. A significant portion of its team consists of a highly qualified sales team that trains vascular surgeons in the use of this less invasive and safer technology.
Number of employees in the market segment - Therapeutic medical equipment
Silk Road Medical, Inc. is a medical device company that has developed an innovative system for treating the carotid artery to reduce the risk of stroke. This chart illustrates employment trends in the vascular surgery sector. The rapid growth in the number of engineers and sales professionals reflects the successful implementation of a new, less invasive technology that is becoming a standard of care.
Number of employees in the market as a whole
Silk Road Medical has developed an innovative system for stroke prevention. Implementation of its technology depends on acceptance by the medical community and insurance coverage. Stable employment, as seen in this graph, provides more patients with quality insurance, facilitating access to advanced and expensive medical procedures.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Silk Road Medical Inc (SILK)
Silk Road Medical is a medical company that has developed and markets a minimally invasive system (TCAR) for the treatment of carotid artery disease (stroke prevention). It is a high-tech MedTech. The chart shows the market value of their proprietary technology. The high market capitalization per employee reflects both the value of their R&D and the high margins of their single-use systems, which their team sells.
%20of%20the%20company%20Silk%20Road%20Medical%20Inc%20(SILK)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Silk-Road-Medical-Inc-SILK&v=1772513750326 "Chart of market capitalization per employee (in thousands of dollars) of the company Silk Road Medical Inc (SILK)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Silk Road Medical has developed and commercialized an innovative procedure to reduce the risk of stroke. It is a medical device company with a patented technology. This chart demonstrates the market's appreciation for its unique treatment approach and its commercial potential, driven by a small but highly effective team.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772513750327 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Silk Road Medical has developed and markets a transcarotid stenting system, a less invasive treatment for carotid artery disease. The chart shows its valuation in the MedTech sector. The high market capitalization per employee reflects the value of their innovative approach, which has the potential to become a new standard of care and save countless lives.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513750328 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Silk Road Medical Inc (SILK)
Silk Road Medical is a medtech company that has changed the game in carotid artery treatment. They developed a minimally invasive procedure (TCAR) to prevent strokes. It's a high-margin business. This chart shows how successful their dedicated sales team is in training doctors and selling these single-use, expensive procedure kits.
%20Chart%20Silk%20Road%20Medical%20Inc%20(SILK)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Silk-Road-Medical-Inc-SILK&v=1772513750330 "Company Profit Per Employee (in thousands of dollars) Chart Silk Road Medical Inc (SILK)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Silk Road Medical is a medical company that has developed an innovative system (TCAR) for preventing strokes during carotid artery surgery. It is a high-margin medical device business. This metric reflects how successfully their sales team promotes this technology to surgeons.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772513750334 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Silk Road Medical is a medical technology company producing devices (TCAR) for the treatment of carotid artery disease (stroke prevention). This includes R&D and manufacturing. This graph demonstrates how their innovative devices are in demand among surgeons and allow them to charge a high price, generating profit per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513750357 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Silk Road Medical Inc (SILK)
Silk Road Medical has developed and markets a system for transcarotid arterial revascularization (TCAR), a minimally invasive procedure for stroke prevention. This chart demonstrates the commercial success of its technology. The growth in revenue per employee indicates the rapid adoption of the TCAR procedure in hospitals across the country.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Silk-Road-Medical-Inc-SILK&v=1772513750360 "Sales chart per company employee Silk Road Medical Inc (SILK)")
Sales per employee in the market segment - Therapeutic medical equipment
Silk Road Medical (SILK) has developed a less invasive method (TCAR) to prevent strokes in patients with carotid artery disease. This graph shows how much revenue each employee (especially their sales team) generates from sales of their disposable surgical kits. This measures their commercial success in the medtech segment.
Sales per employee for the market as a whole
Silk Road Medical (SILK) has developed an innovative system (TCAR) for treating carotid artery stenosis that is less invasive than traditional surgery. It is a medical equipment sales company. This chart shows how effectively the company's sales team is promoting this procedure to vascular surgeons and scaling sales.
Short shares by company, segment and market as a whole
Shares shorted by company Silk Road Medical Inc (SILK)
Silk Road Medical has developed and markets a medical device for the treatment of carotid artery stenosis (stroke prevention). The bearish sentiment shown by this chart is a bet that its minimally invasive procedure (TCAR) will not be widely accepted by surgeons or will not prove superior to traditional methods.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Silk-Road-Medical-Inc-SILK&v=1772513750365 "Short Shares Chart for the Company Silk Road Medical Inc (SILK)")
Shares shorted by market segment - Therapeutic medical equipment
This chart shows investor skepticism toward the vascular surgery sector. Silk Road Medical developed the TCAR system for treating carotid arteries. The growing short position in the industry suggests that investors are skeptical about the speed of adoption of new surgical techniques, fear competition from stents, or anticipate problems with insurance reimbursement.
Shares shorted by the overall market
Silk Road Medical produces innovative devices for the prevention of strokes (TCAR procedure). This chart reflects the overall market pessimism. Investors fear that during a recession, hospitals, in an effort to save money, will freeze purchases of new expensive equipment and perform fewer elective "innovative" surgeries.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Silk Road Medical Inc (SILK)
Silk Road Medical (SILK) revolutionized stroke treatment by creating a less invasive system (TCAR) for carotid artery surgery. It's a medtech success story. This indicator tracks how investors react to their reports of rising procedure volumes, showing "overbought" (above 70) on strong numbers or "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Silk-Road-Medical-Inc-SILK&v=1772513750391 "RSI 14 indicator chart for the company's stock Silk Road Medical Inc (SILK)")
RSI 14 Market Segment - Therapeutic medical equipment
Silk Road Medical is a medical technology company. They developed TCAR, a minimally invasive procedure (and devices) for treating carotid artery stenosis, which reduces the risk of stroke during surgery. This chart measures the overall momentum in the therapeutic medical device sector. It helps assess whether this entire innovative segment is overheated.
RSI 14 for the overall market
Silk Road Medical (SILK) is a biotech R&D company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SILK (Silk Road Medical Inc)
Silk Road Medical revolutionized stroke treatment with the development of the TCAR system. This minimally invasive procedure clears the carotid arteries while protecting the brain. This graph shows the analysts' average 12-month forecast. It reflects their view on how quickly TCAR will become the new standard of treatment, replacing open surgery.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SILK-Silk-Road-Medical-Inc&v=1772513750393 "A chart showing analyst consensus forecasts for the expected stock price. SILK (Silk Road Medical Inc)")
The difference between the consensus estimate and the actual stock price SILK (Silk Road Medical Inc)
Silk Road (SILK) is a stroke reversal system. Their innovative system (TCAR) allows surgeons to reverse blood flow *away* from the brain during carotid artery surgery, protecting it. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and the forecast, reflecting their confidence in the implementation of this "safe" surgery.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SILK-Silk-Road-Medical-Inc&v=1772513750394 "A chart showing the difference between the consensus forecast and the actual stock price. SILK (Silk Road Medical Inc)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Silk Road Medical (SILK) is a company transforming vascular surgery. It has developed a system (TCAR) for the treatment of carotid arteries (stroke prevention) that reverses blood flow during surgery. This chart shows general expectations for the therapeutic medical equipment sector. It reveals whether experts believe in the growth of smart surgery.
Analysts' consensus forecast for the overall market share price
Silk Road Medical (SILK) is a medical technology company that repairs blood vessels in the neck. They have developed TCAR, a new, less invasive procedure to prevent strokes in patients with carotid artery disease. This chart shows the overall risk appetite. It reflects the market's confidence in hospitals' willingness to spend (CapEx) on implementing new, breakthrough technologies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Silk Road Medical Inc
Silk Road Medical has developed an innovative TCAR procedure to prevent strokes in patients with carotid artery disease. This medical technology requires recognition from physicians. This chart is a comprehensive index assessing the speed of adoption of their technology, sales revenue growth, and overall investment attractiveness in the competitive medical equipment industry.
AKIMA Market Segment Index - Therapeutic medical equipment
Silk Road Medical (SILK) is a vascular therapeutic device company. They revolutionized stroke treatment by creating TCAR, a less invasive system for clearing carotid arteries. This chart compares their Innovation Index to the medtech sector average.
The AKIM Index for the overall market
Silk Road Medical is a medtech company pioneering the TCAR procedure for stroke prevention in the carotid artery. It was acquired by Boston Scientific. This chart, reflecting the market average, is a backdrop. It helps assess how Silk, a successful innovation story, stacks up against the backdrop of overall macroeconomic trends.
